{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:14:52Z","timestamp":1790118892176,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40266-023-01010-y","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T06:58:37Z","timestamp":1676789917000},"page":"165-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chronic Urticaria in Older Adults: Treatment Considerations"],"prefix":"10.1007","volume":"40","author":[{"given":"Cataldo","family":"Patruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Torta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Stingeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"issue":"3","key":"1010_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","volume":"77","author":"T Zuberbier","year":"2022","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734\u201366.","journal-title":"Allergy"},{"issue":"6","key":"1010_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100533","volume":"14","author":"M S\u00e1nchez-Borges","year":"2021","unstructured":"S\u00e1nchez-Borges M, Ansotegui IJ, Baiardini I, Bernsteind J, Canonica GW, Ebisawae M, et al. The challenges of chronic urticaria part 1: epidemiology, immunopathogenesis, comorbidities, quality of life, and management. World Allergy Organ J. 2021;14(6): 100533.","journal-title":"World Allergy Organ J"},{"issue":"2","key":"1010_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2133.2005.06976.x","volume":"154","author":"P Staubach","year":"2006","unstructured":"Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154(2):294\u20138.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1010_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1590\/abd1806-4841.20165071","volume":"91","author":"GA Dias","year":"2016","unstructured":"Dias GA, Pires GV, Valle SO, Dortas J\u00fanior SD, Levy S, Fran\u00e7a AT, et al. Impact of chronic urticaria on the quality of life of patients followed up at a university hospital. An Bras Dermatol. 2016;91(6):754\u20139.","journal-title":"An Bras Dermatol"},{"issue":"2","key":"1010_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/all.14037","volume":"75","author":"J Fricke","year":"2020","unstructured":"Fricke J, \u00c1vila G, Keller T, Weller K, Lau S, Maurer M, Zuberbier T, Keil T. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75(2):423\u201332.","journal-title":"Allergy"},{"issue":"1","key":"1010_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","volume":"144","author":"LK Delong","year":"2008","unstructured":"Delong LK, Culler SD, Saini SS, Beck LA, Chen SC. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 non immunosuppressed patients. Arch Dermatol. 2008;144(1):35\u20139.","journal-title":"Arch Dermatol"},{"issue":"3","key":"1010_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/09546634.2016.1227421","volume":"28","author":"MH Mendelson","year":"2017","unstructured":"Mendelson MH, Bernstein JA, Gabriel S, Balp MM, Tian H, Vietri J, Lebwohl M. Patient-reported impact of chronic urticaria compared with psoriasis in the United States. J Dermatol Treat. 2017;28(3):229\u201336.","journal-title":"J Dermatol Treat"},{"key":"1010_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40413-018-0216-1","volume":"11","author":"M Maurer","year":"2018","unstructured":"Maurer M, Houghton K, Costa C, Dabove F, Ensina LF, Gim\u00e9nez-Arnau A, et al. Differences in chronic spontaneous urticaria between Europe and Central\/South America: results of the multi-center real world AWARE study. World Allergy Organ J. 2018;11:32.","journal-title":"World Allergy Organ J"},{"key":"1010_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jaip.2020.03.030","volume":"8","author":"S Saini","year":"2020","unstructured":"Saini S, Shams M, Bernstein JA, Maurer M. Urticaria and angioedema across the ages. J Allergy Clin Immunol Pract. 2020;8:866\u20131874.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1010_CR10","first-page":"3","volume-title":"The ageing and development report: poverty, independence, and the world\u2019s older people","author":"M Gorman","year":"1999","unstructured":"Gorman M. Development and the rights of older people. In: Randel J, German T, Ewing D, editors. The ageing and development report: poverty, independence, and the world\u2019s older people. London: Earthscan Publications Ltd.; 1999. p. 3\u201321."},{"key":"1010_CR11","unstructured":"WHO. Ageing. https:\/\/www.who.int\/health-topics\/ageing#tab=tab_1. Accessed 5 Jan 2023."},{"issue":"4","key":"1010_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40266-015-0249-x","volume":"32","author":"MT Ventura","year":"2015","unstructured":"Ventura MT, Cassano N, Romita P, Vestita M, Foti C, Vena GA. Management of chronic spontaneous urticaria in the elderly. Drugs Aging. 2015;32(4):271\u201382.","journal-title":"Drugs Aging"},{"issue":"3","key":"1010_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3109\/08923973.2011.631549","volume":"34","author":"MT Ventura","year":"2012","unstructured":"Ventura MT, Napolitano S, Buquicchio R, Cecere R, Arsieni A. An approach to urticaria in the elderly patients. Immunopharmacol Immunotoxicol. 2012;34(3):530\u20133.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"1010_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jaad.2019.02.064","volume":"81","author":"S Wertenteil","year":"2019","unstructured":"Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol. 2019;81(1):152\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1010_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/archdermatol.2011.682","volume":"148","author":"YJ Chen","year":"2012","unstructured":"Chen YJ, Wu CY, Shen JL, Chen TT, Chang YT. Cancer risk in patients with chronic urticaria: a population-based cohort study. Arch Dermatol. 2012;148(1):103\u20138.","journal-title":"Arch Dermatol"},{"issue":"1","key":"1010_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jdv.17724","volume":"36","author":"K Weller","year":"2022","unstructured":"Weller K, Maurer M, Bauer A, Wedi B, Wagner N, Schliemann S, et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J Eur Acad Dermatol Venereol. 2022;36(1):91\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1010_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/jcm10020247","volume":"10","author":"M Napolitano","year":"2021","unstructured":"Napolitano M, Fabbrocini G, Stingeni L, Patruno C. Prevalence of chronic inducible urticaria in elderly patients. J Clin Med. 2021;10(2):247.","journal-title":"J Clin Med"},{"issue":"6","key":"1010_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3904\/kjim.2014.29.6.800","volume":"29","author":"GY Ban","year":"2014","unstructured":"Ban GY, Kim MY, Yoo HS, Nahm DH, Ye YM, Shin YS, et al. Clinical features of elderly chronic urticaria. Korean J Intern Med. 2014;29(6):800\u20136.","journal-title":"Korean J Intern Med"},{"issue":"11","key":"1010_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/ijd.12109","volume":"52","author":"E Magen","year":"2013","unstructured":"Magen E, Mishal J, Schlesinger M. Clinical and laboratory features of chronic idiopathic urticaria in the elderly. Int J Dermatol. 2013;52(11):1387\u201391.","journal-title":"Int J Dermatol"},{"issue":"3","key":"1010_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000339869","volume":"160","author":"MT Ventura","year":"2013","unstructured":"Ventura MT, Napolitano S, Menga R, Cecere R, Asero R. Anisakis simplex hypersensitivity is associated with chronic urticaria in endemic areas. Int Arch Allergy Immunol. 2013;160(3):297\u2013300.","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"1010_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/all.12153","volume":"68","author":"M Maurer","year":"2013","unstructured":"Maurer M, Magerl M, Metz M, Siebenhaar F, Weller K, Krause K. Practical algorithm for diagnosing patients with recurrent wheals or angioedema. Allergy. 2013;68(6):816\u20139.","journal-title":"Allergy"},{"issue":"3","key":"1010_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","volume":"125","author":"M Staevska","year":"2010","unstructured":"Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125(3):676\u201382.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1010_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","volume":"123","author":"F Siebenhaar","year":"2009","unstructured":"Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a random-ized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123(3):672\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1010_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1468-3083.2009.03289.x","volume":"23","author":"A Gimenez-Arnau","year":"2009","unstructured":"Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol. 2009;23(9):1088\u201391.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1010_CR25","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjd.14768","volume":"175","author":"S Guillen-Aguinaga","year":"2016","unstructured":"Guillen-Aguinaga S, Jauregui Presa I, Aguinaga-Ontoso E, Guillen-Grima F, Ferrer M. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis. Br J Dermatol. 2016;175(6):1153\u201365.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1010_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2165\/00002512-200522040-00002","volume":"22","author":"J Hansen","year":"2005","unstructured":"Hansen J, Klimek L, H\u00f6rmann K. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging. 2005;22(4):289\u201396.","journal-title":"Drugs Aging"},{"issue":"4","key":"1010_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jaad.2018.01.023","volume":"79","author":"C Antia","year":"2018","unstructured":"Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA. Urticaria: a comprehensive review: treatment of chronic urticaria, special populations, and disease outcomes. J Am Acad Dermatol. 2018;79(4):617\u201333.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"1010_CR28","first-page":"1","volume":"23","author":"I D\u00e1vila","year":"2013","unstructured":"D\u00e1vila I, del Cuvillo A, Mullol J, J\u00e1uregui I, Bartra J, Ferrer M, Montoro J, Sastre J, Valero A. Use of second generation H1 antihistamines in special situations. J Investig Allergol Clin Immunol. 2013;23(Suppl. 1):1\u201316.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"1010_CR29","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0002-9149(99)00124-1","volume":"83","author":"CM Pratt","year":"1999","unstructured":"Pratt CM, Mason J, Russell T, Reynolds R, Ahlbrandt R. Cardiovascular safety of fexofenadine HCl. Am J Cardiol. 1999;83(10):1451\u20134.","journal-title":"Am J Cardiol"},{"issue":"Suppl. 37","key":"1010_CR30","first-page":"67","volume":"52","author":"CM Pratt","year":"1997","unstructured":"Pratt CM, Mason J, Russell T, Ahlbrandt R. Effect of fexofenadine HCl on corrected QT interval (QTc). Allergy. 1997;52(Suppl. 37):67.","journal-title":"Allergy"},{"issue":"5","key":"1010_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14740338.2011.604029","volume":"10","author":"MK Church","year":"2011","unstructured":"Church MK. Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria. Expert Opin Drug Saf. 2011;10(5):779\u201393.","journal-title":"Expert Opin Drug Saf"},{"key":"1010_CR32","unstructured":"UpToDate. Inhibitors and inducers of P-glycoprotein (P-gp) drug efflux pump (P-gp multidrug resistance transporter). https:\/\/www.uptodate.com\/contents\/image\/print?imageKey=EM%2F73326&topicKey=RHEUM%2F1666&source=see_link. Accessed 5 Jan 2023."},{"issue":"6 Pt 2","key":"1010_CR33","first-page":"25","volume":"59","author":"GR Matzke","year":"1987","unstructured":"Matzke GR, Yeh J, Awni WM, Halstenson CE, Chung M. Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Ann Allergy. 1987;59(6 Pt 2):25\u201330.","journal-title":"Ann Allergy"},{"issue":"Suppl. 65","key":"1010_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1034\/j.1398-9995.2001.00101.x","volume":"56","author":"BM Henz","year":"2001","unstructured":"Henz BM. The pharmacologic profile of desloratadine: a review. Allergy. 2001;56(Suppl. 65):7\u201313.","journal-title":"Allergy"},{"issue":"Suppl. 1","key":"1010_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003088-200241001-00003","volume":"41","author":"M Affrime","year":"2002","unstructured":"Affrime M, Gupta S, Banfield C, Cohen A. A pharmacokinetic profile of desloratadine in healthy adults, including elderly. Clin Pharmacokinet. 2002;41(Suppl. 1):13\u20139.","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"1010_CR36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1124\/dmd.106.010488","volume":"34","author":"KH Liu","year":"2006","unstructured":"Liu KH, Kim MG, Lee DJ, Yoon YJ, Kim MJ, Shon JH, et al. Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A. Drug Metab Dispos. 2006;34(11):1793\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"Suppl. 89","key":"1010_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1398-9995.2008.01897.x","volume":"63","author":"J Sastre","year":"2008","unstructured":"Sastre J. Ebastine in allergic rhinitis and chronic idiopathic urticaria. Allergy. 2008;63(Suppl. 89):1\u201320.","journal-title":"Allergy"},{"issue":"Suppl. 1","key":"1010_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2222.1999.00002.x","volume":"29","author":"FE Simons","year":"1999","unstructured":"Simons FE. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation. Clin Exp Allergy. 1999;29(Suppl. 1):3\u20138.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"1010_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/all.13083","volume":"72","author":"AP Kaplan","year":"2017","unstructured":"Kaplan AP, Gim\u00e9nez-Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017;72(4):519\u201333.","journal-title":"Allergy"},{"key":"1010_CR40","doi-asserted-by":"crossref","unstructured":"Maurer M, Ros\u00e9n K, Hsieh HJ, Saini S, Grattan C, Gimen\u00e9z-Arnau A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 7;368(10):924\u201335. (Erratum in: N Engl J Med. 2013 Jun 13;368(24):2340\u20131).","DOI":"10.1056\/NEJMoa1215372"},{"issue":"1","key":"1010_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","volume":"132","author":"A Kaplan","year":"2013","unstructured":"Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, et al. Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132(1):101\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"1010_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14841","volume":"34","author":"E Martina","year":"2021","unstructured":"Martina E, Damiani G, Grieco T, Foti C, Pigatto PDM, Offidani A. It is never too late to treat chronic spontaneous urticaria with omalizumab: real-life data from a multicenter observational study focusing on elderly patients. Dermatol Ther. 2021;34: e14841.","journal-title":"Dermatol Ther"},{"issue":"3","key":"1010_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.anai.2017.12.007","volume":"120","author":"E Nettis","year":"2018","unstructured":"Nettis E, Cegolon L, Di Leo E, Canonica WG, Detoraki A, Italian OCUReL Study Group. Omalizumab in elderly patients with chronic spontaneous urticaria: an Italian real-life experience. Ann Allergy Asthma Immunol. 2018;120(3):318\u201323.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"1010_CR44","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/1346-8138.16370","volume":"49","author":"R Kitao","year":"2022","unstructured":"Kitao R, Oda Y, Washio K, Tai Y, Ono R, Nishigori C, Fukunaga A. Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria. J Dermatol. 2022;49(7):729\u201331.","journal-title":"J Dermatol"},{"key":"1010_CR45","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.2147\/DDDT.S56004","volume":"9","author":"M Labrador-Horrillo","year":"2015","unstructured":"Labrador-Horrillo M, Ferrer M. Profile of omalizumab in the treatment of chronic spontaneous urticaria. Drug Des Devel Ther. 2015;9:4909\u201315.","journal-title":"Drug Des Devel Ther."},{"issue":"8","key":"1010_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","volume":"49","author":"RJ Keizer","year":"2010","unstructured":"Keizer RJ, Huitema AD, Schellens JH, Beijnen JH. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet. 2010;49(8):493\u2013507.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"1010_CR47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/psp4.12224","volume":"6","author":"JT Ryman","year":"2017","unstructured":"Ryman JT, Meibohm B. Pharmacokinetics of monoclonal antibodies. CPT Pharmacomet Syst Pharmacol. 2017;6(9):576\u201388.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1010_CR48","unstructured":"EMA. INN: omalizumab. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xolair-epar-product-information_it.pdf. Accessed 5 Jan 2023."},{"key":"1010_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40521-016-0097-x","volume":"3","author":"I J\u00e1uregui Presa","year":"2016","unstructured":"J\u00e1uregui Presa I, Navajas Rodr\u00edguez B, Ramos Bare\u00f1o B, Gamboa Setien PM, Urrutia Etxebarri I, Antepara EI. Chronic urticaria in special populations: children, pregnancy, lactation and elderly people. Curr Treat Opt Allergy. 2016;3:423\u201338.","journal-title":"Curr Treat Opt Allergy."},{"issue":"10","key":"1010_CR50","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1097\/TP.0b013e31818aa4b6","volume":"86","author":"P Falck","year":"2008","unstructured":"Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, et al. Reduced elimination of cyclosporine A in elderly (65 years) kidney transplant recipients. Transplantation. 2008;86(10):1379\u201383.","journal-title":"Transplantation"},{"issue":"3","key":"1010_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2165\/00002512-199915030-00003","volume":"15","author":"JM Kovarik","year":"1999","unstructured":"Kovarik JM, Koelle EU. Cyclosporin pharmacokinetics in the elderly. Drugs Aging. 1999;15(3):197\u2013205.","journal-title":"Drugs Aging"},{"key":"1010_CR52","unstructured":"Cyclosporine package insert. https:\/\/www.drugs.com\/pro\/cyclosporine.html. Accessed 19 Aug 2022."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01010-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T07:26:31Z","timestamp":1679383591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01010-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01010-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"1 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Cataldo Patruno, Gabriella Fabbrocini, Francesco Cillo, Ginevra Torta, Luca Stingeni, and Maddalena Napolitano have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data reviewed are all in the public domain.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to, read, and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}